CN113632984A - 复方提高胰岛细胞功能的药膳制作方法及工艺 - Google Patents
复方提高胰岛细胞功能的药膳制作方法及工艺 Download PDFInfo
- Publication number
- CN113632984A CN113632984A CN202110933470.3A CN202110933470A CN113632984A CN 113632984 A CN113632984 A CN 113632984A CN 202110933470 A CN202110933470 A CN 202110933470A CN 113632984 A CN113632984 A CN 113632984A
- Authority
- CN
- China
- Prior art keywords
- agent
- preparation
- taking
- islet cells
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004153 islets of langerhan Anatomy 0.000 title claims abstract description 19
- 235000005911 diet Nutrition 0.000 title claims abstract description 17
- 230000037213 diet Effects 0.000 title claims abstract description 17
- 150000001875 compounds Chemical class 0.000 title claims abstract description 12
- 238000000034 method Methods 0.000 title claims abstract description 11
- 230000008569 process Effects 0.000 title claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 34
- 238000002360 preparation method Methods 0.000 claims abstract description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- 239000000126 substance Substances 0.000 claims abstract description 23
- 239000000463 material Substances 0.000 claims abstract description 21
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 14
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract description 11
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 11
- 238000002156 mixing Methods 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 9
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 7
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 7
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 7
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 7
- 235000006533 astragalus Nutrition 0.000 claims abstract description 7
- 238000001914 filtration Methods 0.000 claims abstract description 7
- 238000000227 grinding Methods 0.000 claims abstract description 7
- 229910001220 stainless steel Inorganic materials 0.000 claims abstract description 7
- 239000010935 stainless steel Substances 0.000 claims abstract description 7
- 238000003756 stirring Methods 0.000 claims abstract description 7
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 6
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 6
- 230000009286 beneficial effect Effects 0.000 claims abstract description 5
- 238000000926 separation method Methods 0.000 claims abstract description 5
- 241000218652 Larix Species 0.000 claims abstract description 4
- 235000005590 Larix decidua Nutrition 0.000 claims abstract description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 4
- 238000002791 soaking Methods 0.000 claims abstract description 4
- 240000006766 Cornus mas Species 0.000 claims abstract 2
- 244000301850 Cupressus sempervirens Species 0.000 claims abstract 2
- 240000008042 Zea mays Species 0.000 claims description 39
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 39
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 37
- 235000005822 corn Nutrition 0.000 claims description 37
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 19
- 235000011613 Pinus brutia Nutrition 0.000 claims description 19
- 241000018646 Pinus brutia Species 0.000 claims description 19
- 239000010903 husk Substances 0.000 claims description 18
- 238000001816 cooling Methods 0.000 claims description 17
- 210000000496 pancreas Anatomy 0.000 claims description 14
- 230000010355 oscillation Effects 0.000 claims description 9
- 239000003610 charcoal Substances 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 229950010604 pancreas powder Drugs 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 238000010025 steaming Methods 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 4
- 241000045403 Astragalus propinquus Species 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 239000010902 straw Substances 0.000 claims description 3
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 2
- 235000015097 nutrients Nutrition 0.000 abstract description 9
- 241001061264 Astragalus Species 0.000 abstract description 4
- 210000004233 talus Anatomy 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 238000005374 membrane filtration Methods 0.000 abstract description 2
- 230000000050 nutritive effect Effects 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 description 54
- 239000008280 blood Substances 0.000 description 54
- 230000000694 effects Effects 0.000 description 48
- 210000004072 lung Anatomy 0.000 description 22
- 210000004027 cell Anatomy 0.000 description 21
- 206010012601 diabetes mellitus Diseases 0.000 description 20
- 230000006870 function Effects 0.000 description 20
- 230000007812 deficiency Effects 0.000 description 19
- 210000003734 kidney Anatomy 0.000 description 19
- 239000003814 drug Substances 0.000 description 18
- 230000001737 promoting effect Effects 0.000 description 18
- 210000004185 liver Anatomy 0.000 description 15
- 210000000952 spleen Anatomy 0.000 description 14
- 230000036772 blood pressure Effects 0.000 description 12
- 150000001413 amino acids Chemical class 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 10
- 230000002401 inhibitory effect Effects 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 210000002784 stomach Anatomy 0.000 description 10
- 235000019640 taste Nutrition 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 208000032843 Hemorrhage Diseases 0.000 description 8
- 230000000740 bleeding effect Effects 0.000 description 8
- 210000002216 heart Anatomy 0.000 description 8
- 229910052500 inorganic mineral Inorganic materials 0.000 description 8
- 239000011707 mineral Substances 0.000 description 8
- 235000010755 mineral Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 230000001105 regulatory effect Effects 0.000 description 8
- 210000002700 urine Anatomy 0.000 description 8
- 241000218691 Cupressaceae Species 0.000 description 7
- 238000005728 strengthening Methods 0.000 description 7
- 231100000331 toxic Toxicity 0.000 description 7
- 230000002588 toxic effect Effects 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 210000003414 extremity Anatomy 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 230000027939 micturition Effects 0.000 description 6
- 231100000252 nontoxic Toxicity 0.000 description 6
- 230000003000 nontoxic effect Effects 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 229930182490 saponin Natural products 0.000 description 6
- 150000007949 saponins Chemical class 0.000 description 6
- 230000035922 thirst Effects 0.000 description 6
- 230000017423 tissue regeneration Effects 0.000 description 6
- 230000007935 neutral effect Effects 0.000 description 5
- 231100000862 numbness Toxicity 0.000 description 5
- 230000008439 repair process Effects 0.000 description 5
- 230000035900 sweating Effects 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 241000209020 Cornus Species 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 208000034507 Haematemesis Diseases 0.000 description 4
- 206010027514 Metrorrhagia Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 241000018650 Pinus massoniana Species 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 241000607764 Shigella dysenteriae Species 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 4
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 4
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 4
- HLXRWTJXGMHOFN-XJSNKYLASA-N Verbenalin Chemical compound O([C@@H]1OC=C([C@H]2C(=O)C[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HLXRWTJXGMHOFN-XJSNKYLASA-N 0.000 description 4
- 208000031971 Yin Deficiency Diseases 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 238000002512 chemotherapy Methods 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 229960001231 choline Drugs 0.000 description 4
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 229930003935 flavonoid Natural products 0.000 description 4
- 235000017173 flavonoids Nutrition 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- -1 mucoid Substances 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 230000001502 supplementing effect Effects 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 229940116269 uric acid Drugs 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 229940126673 western medicines Drugs 0.000 description 4
- 206010013954 Dysphoria Diseases 0.000 description 3
- 208000006083 Hypokinesia Diseases 0.000 description 3
- 240000002948 Ophiopogon intermedius Species 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 229940007046 shigella dysenteriae Drugs 0.000 description 3
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 2
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 206010002515 Animal bite Diseases 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241001480043 Arthrodermataceae Species 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 2
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 2
- 206010012218 Delirium Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 208000035240 Disease Resistance Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 208000004044 Hypesthesia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 208000019695 Migraine disease Diseases 0.000 description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 235000011609 Pinus massoniana Nutrition 0.000 description 2
- 235000011610 Pinus tabuliformis Nutrition 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000191963 Staphylococcus epidermidis Species 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 229930183118 Tanshinone Natural products 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- HLXRWTJXGMHOFN-UHFFFAOYSA-N Verbenalin Natural products C12C(C)CC(=O)C2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O HLXRWTJXGMHOFN-UHFFFAOYSA-N 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- 230000003925 brain function Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 235000019504 cigarettes Nutrition 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 208000006111 contracture Diseases 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000037304 dermatophytes Effects 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 235000004879 dioscorea Nutrition 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 230000011132 hemopoiesis Effects 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 235000003642 hunger Nutrition 0.000 description 2
- 208000034783 hypoesthesia Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 231100000405 induce cancer Toxicity 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 208000003243 intestinal obstruction Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 208000007106 menorrhagia Diseases 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 206010027599 migraine Diseases 0.000 description 2
- 229910052750 molybdenum Inorganic materials 0.000 description 2
- 239000011733 molybdenum Substances 0.000 description 2
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 231100000956 nontoxicity Toxicity 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000000053 physical method Methods 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 2
- 235000015500 sitosterol Nutrition 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 150000005856 steroid saponins Chemical class 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 229930189533 tanshinol Natural products 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 229940096998 ursolic acid Drugs 0.000 description 2
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 241000759833 Cornus officinalis Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 231100000861 limb weakness Toxicity 0.000 description 1
- 208000027905 limb weakness Diseases 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000016334 muscle symptom Diseases 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000013139 quantization Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/30—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation
- A23L5/32—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation using phonon wave energy, e.g. sound or ultrasonic waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/39—Pancreas; Islets of Langerhans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Medicines Containing Plant Substances (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Physiology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
Abstract
本发明公开了复方提高胰岛细胞功能的药膳制作方法及工艺,该药膳包括A剂和B剂,其中A剂的制备步骤如下,步骤1:取黄芪12g,山药12g,地骨皮10g,麦冬10g,山茱萸10g,绞股蓝15g,柏树皮12g,丹参10g,落叶松针叶12g,混合后,超微粉碎300目,将物料粉放入不锈钢锅内加入磁化水2000ml,搅匀后浸泡2小时,然后用旺火煎煮5分钟,再改为慢火煎煮8分钟,用300目滤网过滤,取汁。步骤2:用户在申请添加对方为好友时,对方收到请求页上会有“是否愿意进入开放录”好友。有益效果在于:本发明所述药膳物料组合科学合理,将物料细化并用磁化水浸泡有利于各营养物质的析出,同时通过超滤膜过滤,高度浓缩物质精华,使得药膳的营养价值更高。
Description
技术领域
本发明涉及到保健食品技术领域,尤其涉及复方提高胰岛细胞功能的药膳制作方法及工艺。
背景技术
目前,我国糖尿病患者已达上亿人,而且每年均在以6%的速度新增。得了糖尿病以后,大都采用西药和中药治疗,西药虽能立杆见影,但毒副作用大,即是好转后,复发的机率仍然很高。目前利用中药来调治糖尿病效果要好于西药,它能够标本兼治,副作用小,几乎不伤肝肾,但康复后复发的几率也很高。
辅助糖尿病治疗的许多保健食品也很多,但都因功能低、作用差、靶向性的营养补给调节不明显,三多一少等诸多并发症仍很突出,降糖容易但稳糖难,受损的胰岛细胞仍处于潜在性的饥饿和病变现象,辅助药物治疗糖尿病的营养物很难实现受损胰岛细胞的修复,也就出现了目前保健食品多如牛毛、糖尿病患者必须终身服药、注射胰岛素才能基本能够控制的医学难象。
发明内容
本发明的目的就在于为了解决上述问题而提供复方提高胰岛细胞功能的药膳制作方法及工艺。
本发明通过以下技术方案来实现上述目的:
复方提高胰岛细胞功能的药膳制作方法及工艺,该药膳包括A剂和B剂,其中A剂的制备步骤如下:
步骤1:取黄芪12g,山药12g,地骨皮10g,麦冬10g,山茱萸10g,绞股蓝15g,柏树皮12g,丹参10g,落叶松针叶12g,混合后,超微粉碎300目,将物料粉放入不锈钢锅内加入磁化水2000ml,搅匀后浸泡2小时,然后用旺火煎煮5分钟,再改为慢火煎煮8分钟,用300目滤网过滤,取汁,再向料渣内加入磁化水1500ml继续煎煮依次3遍,弃渣,将3遍滤液合并;
步骤2:用小型超滤机,设定超滤膜细度0.3um,压力20Mpa,将合并的料液倒入超滤机内封严,进行超滤分离,滤过后再向滤渣内冲压500ml磁化水,将滤渣内的有益物质冲压入滤液中混合后,取出,放入另一不锈钢容器内,进行间接加热85℃水浴挥发水分,待浓缩至150ml时,取出降温,向内加入SOD10mg,磁化水100ml,搅匀待全部溶解后,再放入一50HZ的超声波振荡器内,超声振荡10分钟,然后取出,作为A剂,待用;
B剂的制备步骤如下:
步骤1:烧制包谷炭,取包谷蕊0.5kg,用包谷秸或包谷皮引火,不得用其它柴草引火,将包谷芯烧制成黑色炭状时在取出,立即弄碎灭火,降温后粉碎80目,剂量为20g;
步骤2:猪胰粉的制法,取鲜猪胰1条,用温碱水清洗去脂,再用清水冲洗干净后绞碎,放入蒸锅内蒸20分钟,取出降温,再放入一真空干燥器内真空冷冻干燥,待含水分低于4%以下时取出,粉碎成80目,称量30g,再与包谷炭粉20g、松花粉20g合并混合为B剂,待用。
进一步的,A剂制备时将各原料进行粉碎的目的是将物料细化,有益于多种物质的析出。
进一步的,A剂制备时超声振荡的目的是通过超声波振荡原理,将料液中的各物质成分超声粉碎比纳米还细的量子微粒化层次,以促使人体更易吸收和利用。
进一步的,B剂制备时1条鲜猪胰经加工后,得干粉30g。
进一步的,A剂和B剂的服用方法为:用开水冲汤后,进行饮用。
进一步的,黄芪味甘,性微温,入脾、肺经,主要功效为补气升阳,益卫固表,托毒生肌,利水退肿,常用于脾肺气虚所致的食少便溏,气短乏力、咳喘,用于气血不足,气虚所致的肢体麻木,关节痹痛,消渴、表虚自汗、汗出恶风、头项疼痛等症状,内含多糖类、胆碱类、叶酸、多种氨基酸等,它能够兴奋中枢神经系统,能增强网状内皮系统的吞噬功能,提高肌体抗病能力,还有利尿作用,能加速尿蛋白消失,还有保护肝脏,防止肝糖元减少的作用,并且对葡萄球菌、链球菌、志贺氏痢疾杆菌等均有抑制作用,因此,利用黄芪即能补脾气,又能固糖尿病患者的肺气,对糖尿病患者的普遍气虚具有十分重要的治疗意义。
进一步的,山药味甘,性平,入脾、肺、肾经,具有益气养阴,调脾胃,益肺肾等功效,主要用于肺虚、肾虚、阴虚内热所致的口渴、消渴、口干舌燥等,内含黏液质、皂甙、胆碱、精氨酸、淀粉酸、淀粉等,利用山药即能补脾气又能养胃阴,对糖尿病的作用意义很大。
进一步的,麦冬味甘,微苦,性微寒,入心、胃、肺经,具有润肺养阴,益胃生津,清心除烦的功效,主要用于糖尿病舌干口燥、口渴少津、心烦不安和失眠。内含各种矿物质、甾体皂甙、黏液质、葡萄糖、谷甾醇等,同时还能对白色葡萄球菌、枯草杆菌、大肠杆菌及伤寒杆菌有抗菌作用。
进一步的,地骨皮味甘淡,性寒,入肺、肾、肝经,具有凉血退蒸、清泻肺热等作用,主要用于阴虚血热、盗汗,骨蒸潮热等作用,肺热咳嗽、血热妄行、吐血、衄血等症,地骨皮具有清虚热和凉血、降血糖、降血压、调节植物神经和内分泌的作用。
进一步的,山茱萸味酸,性微温,入肝、肾经,具有补益肝肾,收敛固涩的作用,用于肝肾亏虚,气血两虚所致的经多、崩漏、血色淡红、头晕目眩、腰膝酸软、四肢无力等症,山茱萸长于平补肝肾,并能敛汗、固崩,内含VA、山茱萸甙、皂甙、鞣质、熊果酸、苹果酸、酒石酸等,有利尿降压作用,对化疗引起的白血球下降,有促生的作用,而且对金黄色葡萄球菌、痢疾杆菌及某些皮肤真菌有抑制作用。
进一步的,丹参味苦,性微寒,入心、肝经,具有活血祛淤、凉血消痛,养血安神的作用,主要用于血滞所致的月经错后、血滞经闭、肢体麻木疼痛,热毒炽盛所致的疮痛肿痛、发热、温病热入营血所致高热、神昏谵语、烦燥不安等,现代医学研究证明,丹参还具有祛淤补血的作用,但祛淤的作用大于补血,并能够祛淤而生新,还能够提高在低压或常压条件下机体的耐缺氧力,能够加快微循环血液流速,增加毛细血管网等作用,能够促进组织修复和再生,有抑制肿瘤细胞生长作用,能够抑制凝血并激活纤溶,对绿脓杆菌、大肠杆菌、变形杆菌等有抑制作用,内含丹参酮甲、丹参酮乙、丹参酮丙、丹参醇等。具有改善外周血液循环,增强免疫力,促进受损细胞再生的作用。
进一步的,绞股蓝性寒、微苦,入脾、肺、肾经,具有调节血压、降低血脂、调节血糖、促进尿酸排泄等功效,主要用于①降压、降脂、降糖;②抗动脉硬化、抑制血栓形成、治疗心脏疾患;③安神养性、延缓衰老、改善脑力活动、提高大脑机能;④活化人体细胞、抑制肥胖、健脾胃、解疲劳,有镇静催眠、抑制紧张、治疗偏头痛;⑤抗癌防癌、抑制并诱杀癌细胞、增强人体血液淋巴细胞的活性、增强免疫力;⑥能够清除激素类药物的毒副作用;⑦消炎、抗肠阻、胃溃疡;⑧对便秘有一定的效果,绞股蓝内含80多种皂甙,还含有丰富的小分子多糖,18种以上的游离氨基酸,丰富的维生素,23种以上的宏量和微量元素,特别是硼、镁、锰、锌、钼、硒、铜等以及丰富的黄酮类化合物。现代医学研究发现,绞股蓝还能够促进人体脂肪类物质代谢,营养人体细胞,同时还有解毒消炎的作用。
进一步的,柏树皮苦、涩,性平,主要作用为凉血止血,敛疮生肌,用于刀伤、吐血、血痢、痔疮、烫伤、动物咬伤、咳血、心气痛以及缩筋症有较好的作用,因此,添加柏树皮能够凉血生肌,对一切受损的皮质、胶质及组织有修复生肌的作用,内含多种氨基酸、矿物质、多糖、双黄酮和三萜类化合物,经多次临床实验表明,柏树皮能有较好的降血糖、降血压、降血脂、降低血胆固醇的作用,而且作用持久、无毒。
进一步的,松花粉是我国特有的乡土树种马尾松和油松的花粉,是松树的精子细胞,它蕴含松树长寿的生命信息和维持生命的全部营养物质,也是松树传宗接代的遗传基因,属木本花粉、花源单一,品质纯净,成分稳定,而且无化学农药等污染,不含任何激素,无异体蛋白,内含200多种营养素:①氨基酸22种;②维生素14种;③矿物质30余种;④各种酶和辅酶100余种;⑤核酸2%;⑥芦丁、不饱和脂肪酸、黄酮类和卵磷脂、纤维素等;松花粉原明松黄,气味甘平,无毒,主治心腹寒热邪气、利小便、消瘀血、久服还能轻身益气力,营养人体所有的细胞,延年益寿。本发明采用的松花粉是烟台新时代集团经破壁1-4微米的国珍松花粉,品质上乘,活力强。
进一步的,SOD是本发明从玉米胚芽中用物理法提取的一种功能酶,生理活性为3000UI/mg国际单位,白色半结晶粉末状,现代药理学研究表明,SOD能够清除人体内过剩自由基,能够减少因放化疗和多种药物产生的不良反应,能够加速各组织细胞的修复,还能够促使骨髓造血功能化,恢复细胞生机的作用,增强体质,实验证实,各型糖尿病在服各种降糖药物同时,配服SOD效果要好于单服降糖药,能够起到较好的辅助疗效,因此加入SOD对清除体内氧化物、修复胰岛细胞功能化,能够起到极其显著的效果。
进一步的,包谷芯是将玉米粒脱掉后,剩余下的玉米棒,称为包谷芯,在将包谷芯烧成黑色炭状,故称包谷炭,包谷炭性平、甘,无毒,具有缩尿止泻、止血抗炎的作用,经药理学研究表明,包谷炭能够抑制尿蛋白和尿糖的发生,还能够减少尿酸指数和降压,清血热,抑制溏泄、便血、水肿等功效。
进一步的,依据中医五行医理,吃胰补胰的理论,添加了特制的猪胰粉,猪胰内含丰富的矿物质、蛋白质、氨基酸、尤其是含有猪胰素,能够对受损胰鸟细胞有较好的营养补充和修复功能。
进一步的,松树叶,性平、涩,无毒,对止咳平喘、清湿毒、止血化痰、固气卫表、消湿疹有较好的治疗作用,本发明采用的是落叶松树的针状叶,内含双黄酮、三萜类化合物以及十多种矿物质、氨基酸、生物素和微量元素硼、镁、锌、铁、硒、铜等营养成分,经多年来实验表明,油松和落叶松针叶具有降脂、降糖、降压、降低胆固醇的作用,而且降糖作用要优于草本植物苦瓜、南瓜等,而且油松和落叶松的针叶无毒,降脂、降糖作用明显而持久。
本发明的有益效果在于:
1、本发明所述药膳物料组合科学合理,将物料细化并用磁化水浸泡有利于各营养物质的析出,同时通过超滤膜过滤,高度浓缩物质精华,使得药膳的营养价值更高;
2、本发明所述药膳通过超声粉碎细胞质,使各药食兼具的物质达到量子化微粒层次并产生磁记忆,进入人体后与各组织细胞电子层受迫共震,就像超声波洗牙一样,快速剥离细胞壁内外黏附着的过剩自由基和各种垃圾毒垢,尤其是胰岛细胞内外的垃圾毒垢,微粒肽的量子物质能够快速进入细胞内,清洗细胞内外环境,迅速佼正因受损的胰岛细胞电子频率的紊乱,而且不损伤正常细胞。由于超氧化物歧化酶SOD的量子化,快速有效的清洗了细胞内外环境,也就减少了过剩自由基对人体各组织细胞,尤其是对胰岛细胞的氧化危害;
3、本发明所述药膳兼具黄芪、山药、山茱萸、麦冬、地骨皮、柏树皮、松针叶、绞股蓝、丹参等中药材的药食作用,一般在服用2天后,绝大多数患者心烦燥热、气虚乏力、多饮多尿、善饥多食、头晕目眩、出虚汗、肢体麻木等症状明显减轻,血糖峰值逐渐下降,并且康复后的诸多患者,无需严格控制饮食,以有利于各组织细胞包括胰岛细胞在内的多元化营养补给。
具体实施方式
复方提高胰岛细胞功能的药膳制作方法及工艺,该药膳包括A剂和B剂,其中A剂的制备步骤如下:
步骤1:取黄芪12g,山药12g,地骨皮10g,麦冬10g,山茱萸10g,绞股蓝15g,柏树皮12g,丹参10g,落叶松针叶12g,混合后,超微粉碎300目,将物料粉放入不锈钢锅内加入磁化水2000ml,搅匀后浸泡2小时,然后用旺火煎煮5分钟,再改为慢火煎煮8分钟,用300目滤网过滤,取汁,再向料渣内加入磁化水1500ml继续煎煮依次3遍,弃渣,将3遍滤液合并;
步骤2:用小型超滤机,设定超滤膜细度0.3um,压力20Mpa,将合并的料液倒入超滤机内封严,进行超滤分离,滤过后再向滤渣内冲压500ml磁化水,将滤渣内的有益物质冲压入滤液中混合后,取出,放入另一不锈钢容器内,进行间接加热85℃水浴挥发水分,待浓缩至150ml时,取出降温,向内加入SOD10mg,磁化水100ml,搅匀待全部溶解后,再放入一50HZ的超声波振荡器内,超声振荡10分钟,然后取出,作为A剂,待用;
B剂的制备步骤如下:
步骤1:烧制包谷炭,取包谷蕊0.5kg,用包谷秸或包谷皮引火,不得用其它柴草引火,将包谷芯烧制成黑色炭状时在取出,立即弄碎灭火,降温后粉碎80目,剂量为20g;
步骤2:猪胰粉的制法,取鲜猪胰1条,用温碱水清洗去脂,再用清水冲洗干净后绞碎,放入蒸锅内蒸20分钟,取出降温,再放入一真空干燥器内真空冷冻干燥,待含水分低于4%以下时取出,粉碎成80目,称量30g,再与包谷炭粉20g、松花粉20g合并混合为B剂,待用。
本实施例中,A剂制备时将各原料进行粉碎的目的是将物料细化,有益于多种物质的析出。
本实施例中,A剂制备时超声振荡的目的是通过超声波振荡原理,将料液中的各物质成分超声粉碎比纳米还细的量子微粒化层次,以促使人体更易吸收和利用。
本实施例中,B剂制备时1条鲜猪胰经加工后,得干粉30g。
本实施例中,A剂和B剂的服用方法为:用开水冲汤后,进行饮用。
本实施例中,黄芪味甘,性微温,入脾、肺经,主要功效为补气升阳,益卫固表,托毒生肌,利水退肿,常用于脾肺气虚所致的食少便溏,气短乏力、咳喘,用于气血不足,气虚所致的肢体麻木,关节痹痛,消渴、表虚自汗、汗出恶风、头项疼痛等症状,内含多糖类、胆碱类、叶酸、多种氨基酸等,它能够兴奋中枢神经系统,能增强网状内皮系统的吞噬功能,提高肌体抗病能力,还有利尿作用,能加速尿蛋白消失,还有保护肝脏,防止肝糖元减少的作用,并且对葡萄球菌、链球菌、志贺氏痢疾杆菌等均有抑制作用,因此,利用黄芪即能补脾气,又能固糖尿病患者的肺气,对糖尿病患者的普遍气虚具有十分重要的治疗意义。
本实施例中,山药味甘,性平,入脾、肺、肾经,具有益气养阴,调脾胃,益肺肾等功效,主要用于肺虚、肾虚、阴虚内热所致的口渴、消渴、口干舌燥等,内含黏液质、皂甙、胆碱、精氨酸、淀粉酸、淀粉等,利用山药即能补脾气又能养胃阴,对糖尿病的作用意义很大。
本实施例中,麦冬味甘,微苦,性微寒,入心、胃、肺经,具有润肺养阴,益胃生津,清心除烦的功效,主要用于糖尿病舌干口燥、口渴少津、心烦不安和失眠。内含各种矿物质、甾体皂甙、黏液质、葡萄糖、谷甾醇等,同时还能对白色葡萄球菌、枯草杆菌、大肠杆菌及伤寒杆菌有抗菌作用。
本实施例中,地骨皮味甘淡,性寒,入肺、肾、肝经,具有凉血退蒸、清泻肺热等作用,主要用于阴虚血热、盗汗,骨蒸潮热等作用,肺热咳嗽、血热妄行、吐血、衄血等症,地骨皮具有清虚热和凉血、降血糖、降血压、调节植物神经和内分泌的作用。
本实施例中,山茱萸味酸,性微温,入肝、肾经,具有补益肝肾,收敛固涩的作用,用于肝肾亏虚,气血两虚所致的经多、崩漏、血色淡红、头晕目眩、腰膝酸软、四肢无力等症,山茱萸长于平补肝肾,并能敛汗、固崩,内含VA、山茱萸甙、皂甙、鞣质、熊果酸、苹果酸、酒石酸等,有利尿降压作用,对化疗引起的白血球下降,有促生的作用,而且对金黄色葡萄球菌、痢疾杆菌及某些皮肤真菌有抑制作用。
本实施例中,丹参味苦,性微寒,入心、肝经,具有活血祛淤、凉血消痛,养血安神的作用,主要用于血滞所致的月经错后、血滞经闭、肢体麻木疼痛,热毒炽盛所致的疮痛肿痛、发热、温病热入营血所致高热、神昏谵语、烦燥不安等,现代医学研究证明,丹参还具有祛淤补血的作用,但祛淤的作用大于补血,并能够祛淤而生新,还能够提高在低压或常压条件下机体的耐缺氧力,能够加快微循环血液流速,增加毛细血管网等作用,能够促进组织修复和再生,有抑制肿瘤细胞生长作用,能够抑制凝血并激活纤溶,对绿脓杆菌、大肠杆菌、变形杆菌等有抑制作用,内含丹参酮甲、丹参酮乙、丹参酮丙、丹参醇等。具有改善外周血液循环,增强免疫力,促进受损细胞再生的作用。
本实施例中,绞股蓝性寒、微苦,入脾、肺、肾经,具有调节血压、降低血脂、调节血糖、促进尿酸排泄等功效,主要用于①降压、降脂、降糖;②抗动脉硬化、抑制血栓形成、治疗心脏疾患;③安神养性、延缓衰老、改善脑力活动、提高大脑机能;④活化人体细胞、抑制肥胖、健脾胃、解疲劳,有镇静催眠、抑制紧张、治疗偏头痛;⑤抗癌防癌、抑制并诱杀癌细胞、增强人体血液淋巴细胞的活性、增强免疫力;⑥能够清除激素类药物的毒副作用;⑦消炎、抗肠阻、胃溃疡;⑧对便秘有一定的效果,绞股蓝内含80多种皂甙,还含有丰富的小分子多糖,18种以上的游离氨基酸,丰富的维生素,23种以上的宏量和微量元素,特别是硼、镁、锰、锌、钼、硒、铜等以及丰富的黄酮类化合物。现代医学研究发现,绞股蓝还能够促进人体脂肪类物质代谢,营养人体细胞,同时还有解毒消炎的作用。
本实施例中,柏树皮苦、涩,性平,主要作用为凉血止血,敛疮生肌,用于刀伤、吐血、血痢、痔疮、烫伤、动物咬伤、咳血、心气痛以及缩筋症有较好的作用,因此,添加柏树皮能够凉血生肌,对一切受损的皮质、胶质及组织有修复生肌的作用,内含多种氨基酸、矿物质、多糖、双黄酮和三萜类化合物,经多次临床实验表明,柏树皮能有较好的降血糖、降血压、降血脂、降低血胆固醇的作用,而且作用持久、无毒。
本实施例中,松花粉是我国特有的乡土树种马尾松和油松的花粉,是松树的精子细胞,它蕴含松树长寿的生命信息和维持生命的全部营养物质,也是松树传宗接代的遗传基因,属木本花粉、花源单一,品质纯净,成分稳定,而且无化学农药等污染,不含任何激素,无异体蛋白,内含200多种营养素:①氨基酸22种;②维生素14种;③矿物质30余种;④各种酶和辅酶100余种;⑤核酸2%;⑥芦丁、不饱和脂肪酸、黄酮类和卵磷脂、纤维素等;松花粉原明松黄,气味甘平,无毒,主治心腹寒热邪气、利小便、消瘀血、久服还能轻身益气力,营养人体所有的细胞,延年益寿。本发明采用的松花粉是烟台新时代集团经破壁1-4微米的国珍松花粉,品质上乘,活力强。
本实施例中,SOD是本发明从玉米胚芽中用物理法提取的一种功能酶,生理活性为3000UI/mg国际单位,白色半结晶粉末状,现代药理学研究表明,SOD能够清除人体内过剩自由基,能够减少因放化疗和多种药物产生的不良反应,能够加速各组织细胞的修复,还能够促使骨髓造血功能化,恢复细胞生机的作用,增强体质,实验证实,各型糖尿病在服各种降糖药物同时,配服SOD效果要好于单服降糖药,能够起到较好的辅助疗效,因此加入SOD对清除体内氧化物、修复胰岛细胞功能化,能够起到极其显著的效果。
本实施例中,包谷芯是将玉米粒脱掉后,剩余下的玉米棒,称为包谷芯,在将包谷芯烧成黑色炭状,故称包谷炭,包谷炭性平、甘,无毒,具有缩尿止泻、止血抗炎的作用,经药理学研究表明,包谷炭能够抑制尿蛋白和尿糖的发生,还能够减少尿酸指数和降压,清血热,抑制溏泄、便血、水肿等功效。
本实施例中,依据中医五行医理,吃胰补胰的理论,添加了特制的猪胰粉,猪胰内含丰富的矿物质、蛋白质、氨基酸、尤其是含有猪胰素,能够对受损胰鸟细胞有较好的营养补充和修复功能。
本实施例中,松树叶,性平、涩,无毒,对止咳平喘、清湿毒、止血化痰、固气卫表、消湿疹有较好的治疗作用,本发明采用的是落叶松树的针状叶,内含双黄酮、三萜类化合物以及十多种矿物质、氨基酸、生物素和微量元素硼、镁、锌、铁、硒、铜等营养成分,经多年来实验表明,油松和落叶松针叶具有降脂、降糖、降压、降低胆固醇的作用,而且降糖作用要优于草本植物苦瓜、南瓜等,而且油松和落叶松的针叶无毒,降脂、降糖作用明显而持久。
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (5)
1.复方提高胰岛细胞功能的药膳制作方法及工艺,其特征在于:该药膳包括A剂和B剂,其中A剂的制备步骤如下:
步骤1:取黄芪12g,山药12g,地骨皮10g,麦冬10g,山茱萸10g,绞股蓝15g,柏树皮12g,丹参10g,落叶松针叶12g,混合后,超微粉碎300目,将物料粉放入不锈钢锅内加入磁化水2000ml,搅匀后浸泡2小时,然后用旺火煎煮5分钟,再改为慢火煎煮8分钟,用300目滤网过滤,取汁,再向料渣内加入磁化水1500ml继续煎煮依次3遍,弃渣,将3遍滤液合并;
步骤2:用小型超滤机,设定超滤膜细度0.3um,压力20Mpa,将合并的料液倒入超滤机内封严,进行超滤分离,滤过后再向滤渣内冲压500ml磁化水,将滤渣内的有益物质冲压入滤液中混合后,取出,放入另一不锈钢容器内,进行间接加热85℃水浴挥发水分,待浓缩至150ml时,取出降温,向内加入SOD10mg,磁化水100ml,搅匀待全部溶解后,再放入一50HZ的超声波振荡器内,超声振荡10分钟,然后取出,作为A剂,待用;
B剂的制备步骤如下:
步骤1:烧制包谷炭,取包谷蕊0.5kg,用包谷秸或包谷皮引火,不得用其它柴草引火,将包谷芯烧制成黑色炭状时在取出,立即弄碎灭火,降温后粉碎80目,剂量为20g;
步骤2:猪胰粉的制法,取鲜猪胰1条,用温碱水清洗去脂,再用清水冲洗干净后绞碎,放入蒸锅内蒸20分钟,取出降温,再放入一真空干燥器内真空冷冻干燥,待含水分低于4%以下时取出,粉碎成80目,称量30g,再与包谷炭粉20g、松花粉20g合并混合为B剂,待用。
2.根据权利要求1所述的复方提高胰岛细胞功能的药膳制作方法及工艺,其特征在于:A剂制备时将各原料进行粉碎的目的是将物料细化,有益于多种物质的析出。
3.根据权利要求1所述的复方提高胰岛细胞功能的药膳制作方法及工艺,其特征在于:A剂制备时超声振荡的目的是通过超声波振荡原理,将料液中的各物质成分超声粉碎比纳米还细的量子微粒化层次,以促使人体更易吸收和利用。
4.根据权利要求1所述的复方提高胰岛细胞功能的药膳制作方法及工艺,其特征在于:B剂制备时1条鲜猪胰经加工后,得干粉30g。
5.根据权利要求1所述的复方提高胰岛细胞功能的药膳制作方法及工艺,其特征在于:A剂和B剂的服用方法为:用开水冲汤后,进行饮用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110933470.3A CN113632984A (zh) | 2021-08-14 | 2021-08-14 | 复方提高胰岛细胞功能的药膳制作方法及工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110933470.3A CN113632984A (zh) | 2021-08-14 | 2021-08-14 | 复方提高胰岛细胞功能的药膳制作方法及工艺 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113632984A true CN113632984A (zh) | 2021-11-12 |
Family
ID=78421770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110933470.3A Pending CN113632984A (zh) | 2021-08-14 | 2021-08-14 | 复方提高胰岛细胞功能的药膳制作方法及工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113632984A (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102823867A (zh) * | 2012-09-21 | 2012-12-19 | 林树芳 | 一种能够修复受损胰岛细胞功能化的保健食品 |
-
2021
- 2021-08-14 CN CN202110933470.3A patent/CN113632984A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102823867A (zh) * | 2012-09-21 | 2012-12-19 | 林树芳 | 一种能够修复受损胰岛细胞功能化的保健食品 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103340334B (zh) | 一种淡水鱼饲料及其制备方法 | |
CN102940155B (zh) | 一种樱桃谷鸭的雏鸭饲料及其制备方法 | |
KR20110073717A (ko) | 기능성 식품 및 이의 제조방법 | |
CN104855738A (zh) | 一种猪配合饲料及其制备方法 | |
CN106343343A (zh) | 一种降三高的多穗柯苦荞组合物及其应用 | |
CN105166544A (zh) | 一种猪配合饲料及其制备方法 | |
CN102860429A (zh) | 一种小尾寒羊精饲料及其制备方法 | |
CN103652360A (zh) | 用于治疗猪副伤寒的饲料及其制备方法 | |
CN110214845A (zh) | 一种具有治疗痛风功效的养生茶制备的方法 | |
CN105851592A (zh) | 一种具有缓释效果的母猪乳房炎饲料添加剂及制备方法 | |
CN107019208A (zh) | 一种中药酵素及其制备方法 | |
CN106579109A (zh) | 一种解酒护肝柑橘粉的组合物及其制备方法 | |
CN103478435B (zh) | 用于提高种公禽受精率的中药组合物、饲料及其制备方法 | |
CN105875913A (zh) | 一种红景天茶及其制备方法 | |
CN107712890A (zh) | 一种宁心安神膏滋及其制备方法 | |
CN103960542A (zh) | 一种用于防治猪附红细胞体病的饲料和中药组合物 | |
CN107828581A (zh) | 一种蚕蛹酒及其制备方法 | |
CN113632984A (zh) | 复方提高胰岛细胞功能的药膳制作方法及工艺 | |
CN115089661A (zh) | 辅助调节内分泌代谢并抗癌防癌的人参组合物的应用 | |
CN103860948B (zh) | 用于治疗气滞热壅证急性乳腺炎的中药及其制备方法 | |
CN103566312B (zh) | 一种治疗猪食欲不振的中药组合物 | |
CN111568942A (zh) | 一种用于蓝耳病的功能性添加剂及其制备方法 | |
CN102823867A (zh) | 一种能够修复受损胰岛细胞功能化的保健食品 | |
CN105724813A (zh) | 一种治疗水貂犬瘟热的饲料添加剂及其制备方法 | |
CN105125746B (zh) | 一种治疗便秘的中成药及其汤剂的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |